Detalhe da pesquisa
1.
A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings.
J Acquir Immune Defic Syndr
; 87(1): 680-687, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587510
2.
Standardized metrics can reveal region-specific opportunities in community engagement to aid recruitment in HIV prevention trials.
PLoS One
; 15(9): e0239276, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941520